Stocktoria

InfuSystem Holdings, Inc INFU

NYSE · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2006-06-15 · LEI

InfuSystem Holdings, Inc statistics & valuation

Market cap$199.4M
P / E30.1×
P / S1.4×
P / B3.5×
P / FCF8.4×
Net margin4.6%
Return on equity11.6%
FCF margin16.6%
Net debt$16.4M
Net debt / EBITDA0.7×
Enterprise value USD$215.8M
EV / EBITDA8.6×
Earnings yield EBIT/EV5.5%
Return on capital14.8%
Graham number -65.7%$4.35

Market cap as of 2026-06-30. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($4.35); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
-0.30% -29.10% -1.60% 1.70% 17.80% 1.40% 0.00% 0.70% 1.70% 4.60% 2016201720182019202020212022202320242025
Gross margin (%)
63.50% 61.00% 58.90% 57.80% 60.30% 57.20% 55.10% 50.20% 52.20% 56.00% 2016201720182019202020212022202320242025
Operating margin (%)
1.40% -5.40% 0.60% 4.30% 9.10% 2.80% 1.50% 3.20% 5.10% 8.30% 2016201720182019202020212022202320242025
Return on equity (%)
-0.40% -66.90% -5.40% 6.10% 42.50% 2.90% 0.00% 1.70% 4.10% 11.60% 2016201720182019202020212022202320242025
Shares outstanding
22.7M 22.8M 21.4M 20.8M 21.7M 22.0M 21.5M 21.6M 21.7M 21.1M 2016201720182019202020212022202320242025
Net debt ($)
$28.5M $24.9M $29.4M $35.7M $29.2M $32.9M $33.0M $28.9M $23.3M $16.4M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-0.20% -30.10% -1.70% 1.70% 17.90% 1.50% 0.00% 0.80% 2.30% 6.60% 2016201720182019202020212022202320242025
Free cash flow margin (%)
11.00% 10.70% 16.50% 13.50% 19.70% 16.90% 15.00% 8.10% 14.40% 16.60% 2016201720182019202020212022202320242025
Debt / equity (×)
0.63× 0.92× 1.65× 1.72× 0.95× 0.69× 0.69× 0.56× 0.41× 0.34× 2016201720182019202020212022202320242025
EPS ($)
-$0.01 -$0.91 -$0.05 $0.07 $0.80 $0.06 $0.00 $0.04 $0.11 $0.31 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

InfuSystem Holdings, Inc trades at about 41× earnings — above its 10-year norm (10-year range 18.4×–251.7×, median 37.3×).

18.4× 251.7×

Shaded band = 10-year range (18.4×–251.7×); dot = today's 41×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross margin56.0%52.2%50.2%55.1%57.2%60.3%57.8%58.9%61.0%63.5%
Operating margin8.3%5.1%3.2%1.5%2.8%9.1%4.3%0.6%-5.4%1.4%
Net margin4.6%1.7%0.7%0.0%1.4%17.8%1.7%-1.6%-29.1%-0.3%
FCF margin16.6%14.4%8.1%15.0%16.9%19.7%13.5%16.5%10.7%11.0%
Return on assets6.6%2.3%0.8%0.0%1.5%17.9%1.7%-1.7%-30.1%-0.2%
Return on equity11.6%4.1%1.7%0.0%2.9%42.5%6.1%-5.4%-66.9%-0.4%
Debt / equity0.34×0.41×0.56×0.69×0.69×0.95×1.72×1.65×0.92×0.63×
Current ratio1.801.821.951.711.711.290.881.191.421.26

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.